Concepedia

Matthew E. Cuellar

ME

Statistics

Publications

15

Citations

619

H-Index

13

Active since

2006

Affiliations

University of Minnesota(Current)

Brigham and Women's Hospital

Monash University

Nanjing Tech University

The University of Melbourne

Matthew E. Cuellar is an author at University of Minnesota specializing in medicinal chemistry, pharmacy, and drug discovery.

ORCID

Publications per year

2006–2023

15

Publications

15

Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors

Jayme L. Dahlin, Kathryn M. Nelson, Jessica M. Strasser et al. · Nature Communications · 2017 · 106 citations · Full text

, , +14

PABA/NO as an Anticancer Lead:  Analogue Synthesis, Structure Revision, Solution Chemistry, Reactivity toward Glutathione, and in Vitro Activity

Joseph E. Saavedra, Aloka Srinivasan, Gregory S. Buzard et al. · Journal of Medicinal Chemistry · 2006 · 91 citations · Full text

, , +17

A small molecule receptor that selectively recognizes trimethyl lysine in a histonepeptide with native protein-like affinity

Lindsey A. Ingerman, Matthew E. Cuellar, Marcey L. Waters · Chemical Communications · 2010 · 89 citations

, , +17

GSTO1-1 plays a pro-inflammatory role in models of inflammation, colitis and obesity

Deepthi Menon, Ashlee Innes, Aaron J. Oakley et al. · Scientific Reports · 2017 · 64 citations · Full text

, , +16

Reference compounds for characterizing cellular injury in high-content cellular morphology assays

Jayme L. Dahlin, Bruce K. Hua, Beth E. Zucconi et al. · Nature Communications · 2023 · 41 citations · Full text

, , +17

1–5 of 15